期刊文献+

小肠维持胆固醇稳态在预防动脉粥样硬化中的作用 被引量:5

Maintaining Cholesterol Homeostasis in Small Intestine for the Prevention of Atherosclerosis
下载PDF
导出
摘要 胆固醇是影响机体生命活动的重要脂类物质之一,血中胆固醇浓度过高,沉积于大、中动脉内膜中,形成粥样斑块,引起内皮损伤、脂质浸润,是动脉粥样硬化(AS)形成与发展的机制。目前降胆固醇药物的研发主要针对肝脏合成胆固醇的功能,而小肠是胆固醇代谢的主要场所,参与维持机体胆固醇内稳态。肠道维持胆固醇稳态是通过一个复杂的平衡机制调节的,涉及胆固醇吸收、转化与排泄及脂蛋白合成等不同阶段。本文总结了小肠胆固醇代谢途径内的分子调控机制及其与AS形成相关性的研究进展,希望能为治疗AS疾病提供新的诊疗思路。 Cholesterol is an important lipid that significantly affects life.High blood cholesterol level can lead to the cholesterol deposition on the intima of large and middle arteries,and the formation of atherosclerotic plaques,which can trigger endothelial injury and lipid infiltration and finally induce atherosclerosis(AS).Up to now R&D of cholesterol-lowering drugs are mainly focused on the the function of liver in cholesterol synthesis.Notably,the small intestine is the major site of cholesterol metabolism and is involved in maintaining the homeostasis of cholesterol.Gut maintains the cholesterol homeostasis through a complex regulatory mechanism that involves different stages including cholesterol absorption,transformation,and excretion as well as lipoprotein synthesis.In this article we summarizes the research advances in the molecular regulation of cholesterol metabolism in small intestine and its relationship with AS,with an attempt to provide a new insight into the diagnosis and treatment of atherosclerotic disease.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2018年第1期104-111,共8页 Acta Academiae Medicinae Sinicae
基金 国家自然科学基金(81403217)~~
关键词 小肠 胆固醇 动脉粥样硬化 胆汁酸 脂蛋白合成 small intestine cholesterol atherosclerosis bile acid lipoprotein synthesis
  • 相关文献

参考文献2

二级参考文献45

  • 1LibbyP, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317- 25.
  • 2. Cuchel M, Rader DJ. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 2006; 113: 2548-55.
  • 3Van Eck M, Pennings M, Hoekstra M, Out R, Van Berkel TJ. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 2005; 16: 307-15.
  • 4Attie AD, Kastelein JP, Hayden MR. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res 2001; 42: 1717-26.
  • 5Yancey PG, BortnJck AE, Kellner-Weibel G, de la Llera-Moya M, Phillips MC, Rothbiat GH. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Bio12003; 23: 712-9.
  • 6Rogler G, Trumbach B, Klima B, Lackner K_I, Schmitz G. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler Thromb Vasc Biol 1995; 15: 683-90.
  • 7Remaley AT, Schumacher UK, Stonik JA, Farsi BD, Nazih H, Brewer HB Jr. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux.Arterioscler Thromb Vasc Bio11997; 17: 1813-21.
  • 8Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, et al. The Tangier disease gene product ABCl controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999; 104: R25-31.
  • 9Joyce CW, Amar M J, Lambert G, Vaisman BL, Paigen B, Najib-Fruchart J, et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci U S A 2002; 99: 407-12.
  • 10Aiello RJ. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscier Thromb Vasc Biol 2002; 22: 630-7.

共引文献25

同被引文献50

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部